Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Jiménez Navarro M, Avanzas P, Valencia F, Ballesteros S, Ruiz-Nodar JM, Ferreiro JL, Tello Montoliu A, Marín F; Expert Reviewers for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Pérez de Prado A, Romero Moreno M, Bravo MS, Ruiz Ortiz M, Escobar C, Roldán I, Vivas Balcones D; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R.
SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease, et al. Among authors: vivas balcones d.
Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):6-12. doi: 10.1016/j.rec.2017.11.019.
Rev Esp Cardiol (Engl Ed). 2018.
PMID: 29277237
English, Spanish.
No abstract available.